Log In
BCIQ
Print this Print this
 

MAP kinase kinase 1 (MAP2K1) (MEK1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting MAP kinase kinase 1 (MAP2K1) (MEK1)

BCIQ
Print ChartPrint this
3 1 3 1 1
Phases of DevelopmentPhase IPhase I/IIPhase IIApprovedMarketed
Cancer

3

1

3

1

1




 Products Targeting MAP kinase kinase 1 (MAP2K1) (MEK1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$17,034.0M

$14,800.0M

$2,234.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today